Editas Medicine (EDIT)
(Delayed Data from NSDQ)
$5.71 USD
+0.39 (7.33%)
Updated May 13, 2024 04:00 PM ET
After-Market: $5.75 +0.04 (0.70%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/07/2024
Time: -- |
6/2024 | $-0.68 | -5.31% |
Earnings Summary
For their last quarter, Editas Medicine (EDIT) reported earnings of -$0.76 per share, missing the Zacks Consensus Estimate of -$0.63 per share. This reflects a negative earnings surprise of 20.63%. Look out for EDIT's next earnings release expected on August 07, 2024. For the next earning release, we expect the company to report earnings of -$0.68 per share, reflecting a year-over-year decrease of 21.43%.
Earnings History
Price & Consensus
Zacks News for EDIT
Editas Medicine (EDIT) Reports Q1 Loss, Misses Revenue Estimates
EDIT: What are Zacks experts saying now?
Zacks Private Portfolio Services